According to the latest report by IMARC Group titled, “Organ Preservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global organ preservation market grew at a CAGR of 6.5% during 2014-2019.
Organ preservation refers to the process of preserving the healthy organ that is received from a donor until it is transplanted into the body of the receiver. It is performed using numerous techniques, which include static cold storage (SCS), hypothermic machine perfusion and normothermic machine perfusion (NMP), to maintain the temperature and oxygen levels of kidneys, liver, lungs, heart and other organs. Amongst these, static cold storage (SCS) currently represents one of the widely preferred methods to minimize tissue damage and keep organs feasible before transplantation.
The rising geriatric population represents one of the key factors escalating the demand for organ preservation as older people are more prone to health problems and organ failure. Additionally, several governing and non-governing authorities are encouraging organ donation, which in turn is propelling the market growth. Other than this, the introduction of innovative and advanced solutions, such as Celsior and Collins solutions, are expected to create a positive outlook for the market in the coming years.
Request to get the sample report: https://www.imarcgroup.com/organ-preservation-market/requestsample
Insights on Market Segmentation:
Market Breakup by Preservation Solution:
Market Breakup by Organ Donation Type:
Living Organ Donation
Deceased Organ Donation
Market Breakup by Technique:
Static Cold Storage Technique
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/organ-preservation-market
Market Breakup by Organ Type:
Market Breakup by End-User:
Hospitals and Clinics
Market Breakup by Region:
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being 21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems, Xvivo Perfusion, etc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St
Sheridan, WY 82801
Email: [email protected]
Follow us on twitter: @imarcglobal
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.